関連する実験動画
Updated: May 9, 2026

10:38
Culturing of Human Nasal Epithelial Cells at the Air Liquid Interface
Published on: October 9, 2013
支氣管上皮細胞によるアポプトシス細胞クリアランスは,呼吸道炎症に重大な影響を及ぼします
Ignacio J Juncadella1, Alexandra Kadl, Ashish K Sharma
1Carter Immunology Center, University of Virginia, Charlottesville, Virginia 22908, USA.
Nature
|December 14, 2012
まとめ
呼吸道上皮細胞は,Rac1信号伝達を通じてアポプトティック細胞をクリアし,炎症を軽減します. このプロセスの欠陥は,アレルギー性呼吸道反応を悪化させ,Rac1を強調する.
科学分野:
- 免疫学 免疫学とは
- 細胞生物学 細胞生物学
- 呼吸器医学とは
背景:
- 肺上皮細胞は,呼吸道アレルゲンに対する免疫反応を調節する.
- 呼吸道上皮細胞のアポトーシスは,アレルゲン被曝時に起こりますが,クリアランスメカニズムとその炎症効果は十分に理解されていません.
研究 の 目的:
- 呼吸道上皮細胞がアポプトシス細胞をクリアする役割を調査する.
- このプロセスにおける小さなGTPase Rac1の関与と,呼吸道炎症とアレルゲンに対する免疫反応への影響を決定する.
主な方法:
- 特定の呼吸道上皮細胞におけるRac1の誘導式消去を伴うマウスモデルを使用した.
- アポプトシス細胞の吸収,サイトカインの産生,および鼻内アレルゲン誘発後の炎症反応の評価 (家粉のエキス,オバルブミン).
- 測定されたTh2サイトカイン,インタールイキン-10 (IL-10),IL-33およびヌオサイト型細胞集団.
主要な成果:
- Rac1欠乏の呼吸道上皮細胞は,アポプトシス細胞の吸収が損なわれ,抗炎症性サイトカインの分泌が変化していた.
- Rac1欠乏症は,呼吸道炎症を悪化させ,Th2とIL-33のレベルを上昇させ,呼吸道過剰反応を引き起こした.
- IL-10の投与は,Rac1欠乏したマウスの炎症性フェノタイプを改善した.
結論:
- 呼吸道上皮細胞によるRac1依存の包み込みは,抗炎症環境の確立に不可欠です.
- 呼吸道上皮細胞クリアランスの欠陥は,一般的なアレルゲンに対する炎症反応に寄与する.
- この研究は,Rac1が呼吸道炎症と免疫ホメオスタシスを調節する新たな役割を明らかにしています.
関連する概念動画
Phagocytosis of Apoptotic Cells
Cells undergoing apoptosis form apoptotic bodies that must be removed immediately to prevent inflammation, autoimmune diseases, and necrosis. Phagocytosis is carried out by professional phagocytes such as macrophages or immature dendritic cells. Non-professional phagocytes such as epithelial cells and fibroblasts also take part in this process; however, they are not as effective as professional phagocytes.
Normal cells contain receptors that prevent them from being recognized by phagocytes.
Normal cells contain receptors that prevent them from being recognized by phagocytes.
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
Asthma-II: Pathophysiology and Classification
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Asthma I: Introduction
Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
Chronic Obstructive Pulmonary Disease II: Emphysema
Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...

